Coronavirus, COVID-19 Public Health Advisory
[Revised February 22, 2021]
- Feb. 10, 2021 American College of Rheumatology: Guidance on COVID-19 vaccines.
- Jan. 8, 2021 MSAB Statement: Questions and Answers Regarding the COVID-19 Vaccine
- Dec. 15, 2020 Webinar Recording: "Scleroderma and COVID-19," Leroy Griffing, M.D., Mayo Clinic Arizona Scleroderma Program
- Oct. 21, 2020 WEBINAR Coping with Both a Pandemic & Scleroderma, Lee Shapiro, M.D.
- May 1, 2020 UPDATED Statement COVID-19 (Coronavirus) Information & Recommendations
- April 24, 2020 Webinar Recording: "Balancing Your Immune System: A Special Webinar on Nutrition for Scleroderma Patients," Elizabeth R. Volkmann, M.D., M.S., University of California, Los Angeles
- April 16, 2020 Webinar Recording: "Taking Care of Yourself at Home: Maintaining Hand and Face Mobility," Janet Poole, Ph.D., University of New Mexico"
- March 27, 2020 Webinar Recording: "Staying Well During COVID-19," Tracy Frech, M.D., M.S., University of Utah
- March 21, 2020 Video Forum Recording "Scleroderma & COVID-19: A Conversation with the Experts"
- March 21, 2020 Statement "Important Information Related to COVID-19 and Juvenile Scleroderma
- March 20, 2020 Message from Scleroderma Foundation CEO, Robert J. Riggs
- 1 April 2020 Información Importante Traducida al Español Sobre COVID-19 y Esclerodermia Juvenil
- 30 March 2020 Español "COVID-2019 ("Coronavirus") Información y Recomendaciones del Comité de Asesoría Médica y Científica de la Fundación de la Esclerodermia
Your health and safety and that of every person affected by scleroderma is of paramount importance to the Scleroderma Foundation. The Foundation takes very seriously the threat the coronavirus (COVID-19) presents to individuals living with scleroderma, who are immuno-compromised. As the virus spreads in the United States, we wish to provide you with reliable information from qualified sources to guide you in your decision making regarding support group meetings, chapter events, and the activities of daily life.
The Foundation is guided by the directives and recommendations of the Centers for Disease Control & Prevention (CDC), state departments of public health, and the Foundation's Medical & Scientific Advisory Board.
For your reference, the department of public health for each state is listed at the end of this page.
Many municipalities and states have issued prohibitions against gatherings ranging in size from 10 people and larger. Schools and government offices are closing for extended periods of time. Please consult with public health officials in your community to learn the current status of public gatherings and heed their recommendations.
Meetings and Events
- In consultation with the Leadership Committee of the Scleroderma Foundation's Medical & Scientific Advisory Board, chapters and support groups are strongly urged to suspend, cancel, or reschedule in-person meetings and events until further notice. These activities include indoor meetings such as in-person support group meetings, patient education events, and fundraisers. (Please note that fundraising may be easily done online.)
- This action is in line with recommendations from the U.S. Centers for Disease Control & Prevention and our own Medical and Scientific Advisory Board that encourage—and in some municipalities, mandatinge— social distancing.
- Support group leaders should consider the option of using virtual meeting tools, such as Zoom.com, or telephone conferencing during this period of limited public gatherings.
National Patient Education Conference and Kids Get Scleroderma, Too!
- To protect the health of individuals who have scleroderma, the Scleroderma Foundation canceled its 2020 National Patient Education Conference and Kids Get Scleroderma, Too! conference, which were both scheduled to take place July 17-19 in Bellevue, Washington.
- This decision was taken after thorough review of information available through public health agencies, primarily the Centers for Disease Control & Prevention and the State of Washington Public Health Department.
- In lieu of the eagerly anticipated in-person educational conference and the unique and essential personal connections it provides; the Scleroderma Foundation developed the Virtual University patient education series. A total of 18 webinars were presented from July through November, which were video recorded and can be viewed on the Foundation's YouTube channel.
- A full refund of conference fees was given automatically between March 16 and 20 to all who were registered to attend.
- Cancellation of hotel room reservations were the responsibility of the individuals holding the reservations.
- The conference will return to Bellevue, Washington in 2022. The announcement of the location for the 2021 National Conference and KGS2 is pending.
Remember, common flu precautions are also recommended by public health officials to protect against the coronavirus.
- Wash your hands with hot, soapy water for at least 20 seconds.
- Cover your mouth, ideally with an elbow, when you cough or sneeze.
- Social distancing. Limit your activity in public as much as possible. When in public, keep your distance from others; six to ten feet is best; three feet at minimum.
- Get a flu shot. It won't prevent coronavirus, but it will help keep you out of the doctor's office with the flu.
- Use your sick days. If you're not feeling well, stay home and get better.
The CDC is the best primary source for information on the coronavirus:
- Centers for Disease Control & Prevention
Health Resources for Respiratory Complications:
- American Thoracic Society
- American College of Rheumatology
- Pulmonary Hypertension Association
- PRES (Paediatric Rheumatology European Society) Recommendations COVID-19 for Juvenile Scleroderma
Video Presentations on Scleroderma & COVID-19
National Association of County & City Health Officials
(Links to local health officials across the United States)
Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut | Delaware | Florida | Georgia | Hawaii
Idaho | Illinois | Indiana | Iowa | Kansas | Kentucky | Louisiana | Maine | Maryland | Massachusetts | Michigan
Minnesota | Mississippi | Missouri | Montana | Nebraska | Nevada | New Hampshire | New Jersey | New Mexico
New York | North Carolina | North Dakota | Ohio | Oklahoma | Oregon | Pennsylvania | Rhode Island
South Carolina | South Dakota | Tennessee | Texas | Utah | Vermont | Virginia | Washington | West Virginia
Wisconsin | Wyoming